Reiser PJ, Moravec CS. Sex differences in myosin heavy chain isoforms of human failing and nonfailing atria. Am J Physiol Heart Circ Physiol 307: H265-H272, 2014. First published May 30, 2014 doi:10.1152/ajpheart.00810.2013.-Mammalian hearts express two myosin heavy chain (MHC) isoforms, which drive contractions with different kinetics and power-generating ability. The expression of the isoform that is associated with more rapid contraction kinetics and greater power output, MHC-␣, is downregulated, with a concurrent increase in the relative amount of the slower isoform, MHC-␤, during the progression to experimentally induced or disease-related heart failure. This change in protein expression has been well studied in right and left ventricles in heart failure models and in humans with failure. Relatively little quantitative data exists regarding MHC isoform expression shifts in human failing atria. We previously reported significant increases in the relative amount of MHC-␤ in the human failing left atrium. The results of that study suggested that there might be a sex-related difference in the level of MHC-␤ in the left atrium, but the number of female subjects was insufficient for statistical analysis. The objective of this study was to test whether there is, in fact, a sex-related difference in the level of MHC-␤ in the right and left atria of humans with cardiomyopathy. The results indicate that significant differences exist in atrial MHC isoform expression between men and women who are in failure. The results also revealed an unexpected twofold greater amount of MHC-␤ in the nonfailing left atrium of women, compared with men. The observed sex-related differences in MHC isoform expression could impact ventricular diastolic filling during normal daily activities, as well as during physiologically stressful events.
TWO MYOSIN HEAVY CHAIN (MHC) isoforms are expressed in the atria and ventricles of mammals (9) . MHC-␣ predominates in the atria and ventricles of mammalian species with small body mass, such as mice and rats, and in the atria of most mammals. The relative amount (percentage of total MHC) of MHC-␤ increases in the atria and ventricles with increasing species adult body mass and decreasing resting heart rate (23) . MHC-␤ normally constitutes about 25% of the total MHC in the left and right atria and more than 95% in both ventricles in humans (41) . The relative amounts of MHC-␤ transcript and protein increase during the progression of experimentally induced heart failure (3, 10, 16) . MHC-␤ transcript and protein levels are also greater in the atria and ventricles of the failing human heart (13, 31, 32, 39, 41) . The relative amounts of the two cardiac MHC isoforms also change in association with physiological adaptation to variation in workload, such as during exercise training (22, 49) and during hibernation, in which heart rate and cardiac output decrease markedly (2) . Therefore, there are marked differences in the relative amounts of the two cardiac MHC isoforms that are species-specific and that are associated with cardiomyopathy and with physiological adaptations.
It is clear from a large number of reported studies that MHC isoforms are major determinants of contractile properties of the myocardium, as revealed by studies on whole hearts, in vivo and in vitro (11) , as well as isolated cardiac strips or papillary muscles (7, 29, 35) , myocytes (18) , myofibrils (38) , and isolated myosin molecules (1, 36, 48) . The observations from these studies converge onto the broadly accepted conclusions that MHC-␣ is associated with faster contractile kinetics and greater power output, compared with MHC-␤, which is associated with slower and more economical contractions (20, 34) . Therefore, knowledge of the cardiac MHC isoform profile of the atria and ventricles is important to understand not only normal cardiac function in healthy individuals but also the changes that occur in the heart during the progression to failure. There are reported alterations in isoform expression patterns and post-translational modifications of several sarcomeric proteins in association with various forms of heart failure. Specific changes in sarcomeric proteins include a shift to a more compliant isoform of titin (28) , reduced troponin-I phosphorylation and increased myosin light chain 2 phosphorylation (53) , and oxidation or nitrosylation of myosin subunits, actin, tropomyosin, troponin I and T, myosin binding protein-C, ␣-actinin, and titin (47, 52) (reviewed in Ref. 14) . Each of these alterations and modifications has the potential to significantly affect myocardial contractility. This study was focused specifically on expression patterns of cardiac MHC isoforms, given the prominent role of MHC in regulating contractile properties of all types of muscle -cardiac, skeletal, and smooth.
We previously reported a significantly greater amount of MHC-␤ in the left atrium of men and women with dilated cardiomyopathy (DCM) or ischemic cardiomyopathy (ICM), compared with subjects who were not in failure. Samples from the left atrium, as well as the left and right ventricles, of 20 men and five women with either DCM or ICM, in addition to nonfailing individuals, were analyzed in the previous study. The relative amounts of MHC-␤ in the left atrial samples of four of the women with cardiomyopathy were markedly elevated, compared with the mean relative amount in the left atria of failing men, suggesting a possible sex difference in MHC isoform expression in, at least, the failing left atrium. We, therefore, undertook an analysis of the relative amount of MHC-␤ in both atria of similar numbers of men and women, either with or without cardiomyopathy. The results reveal an unexpected and significant sex-related difference in the relative amount of MHC-␤ among individuals without cardiomyopathy in the left atrium, with the amount of MHC-␤ being twofold greater in women, as well as an interaction between sex and heart condition in the right atrium. The results also revealed an increase in the relative amount of MHC-␤, with increasing age, among nonfailing and failing hearts of women, but not of men.
METHODS
Human heart tissue was obtained from two sources. Failing heart tissue was obtained from the explanted hearts of cardiac transplant recipients [20 men, 33-70 years old (average age: 57 years), and 20 women, 28 -67 years old (average age: 54 years)] at Cleveland Clinic, after informed consent. All of these patients had left-sided heart failure. The existence of right-sided failure in these patients is not known. Hearts were arrested with cardioplegic solution in the operating room and rapidly transported to the laboratory, where tissue was divided by cardiac chamber and frozen immediately in liquid nitrogen. Tissue was stored at Ϫ80°C until use. Nonfailing heart tissue was obtained from the hearts of unmatched organ donors [19 men, 17-69 years old (average age: 48 years), and 18 women, 26 -71 years old (average age: 53 years; results from a 26-year-old nonfailing woman are presented separately, due to a prevailing medical condition)], after familial consent. Hearts were arrested with cardioplegia, rapidly explanted, and transported to the Cleveland Clinic from the donor hospital, where they were frozen in liquid nitrogen and stored at Ϫ80°C until use. All tissue procurement protocols were approved by the Institutional Review Board at the Cleveland Clinic. Ejection fraction is included as a subject characteristic. For the failing hearts, ejection fraction was measured at the patient's last clinical visit before heart transplantation, less than 90 days before transplant. For the nonfailing hearts, where an ejection fraction was available, it was measured immediately before explant, during the evaluation of the suitability of the organ for transplant.
Samples of both atria were analyzed for all of the subjects, except for three nonfailing men, one failing man, and one failing woman for which either a left or right atrial sample was analyzed. Muscle tissue, free of visible fat and connective tissue, was isolated by dissection from each sample and weighed (typically ϳ30 mg). The tissue was homogenized in gel sample buffer (30 l/mg tissue), centrifuged for 3 to 4 min at 12,000 rpm in an Eppendorf 5415 centrifuge (5). The pellet was discarded, and the supernatant was transferred to another tube, heated at 65°C for 2 min, and immediately chilled on ice for 5 min. An aliquot was diluted (1:10) with the same buffer before gel loading. Approximately 2 g of total protein (estimated as in Ref. 41) of each sample were loaded on gels (16 cm ϫ 18 cm, and 0.75 mm thick). The stacking and separating gels were modifications of the gel system described by Talmadge and Roy (50) . The stacking gels consisted of 4% (wt/vol) total acrylamide, with an acrylamide:N,N=-methylene-bis-acrylamide ratio of 50:1, 5% (vol/vol) glycerol, 70 mM Tris (stock solution consisted of 0.5 M Tris, titrated to pH 6.8 with HCl), 4 mM EDTA, and 0.4% (wt/vol) SDS. Ammonium persulfate and TEMED [final concentrations: 0.15% (wt/vol) and 0.15% (vt/vol), respectively] were added after 30 min of degassing the gel solution. The separating gels consisted of 6% (wt/vol) total acrylamide, with an acrylamide:N,N=-methylene-bis-acrylamide ratio of 50:1, 5% (vol/ vol) glycerol, 200 mM Tris (stock solution consisted of 2.15 M Tris and 0.85 M Tris·HCl, titrated to pH 8.8 with HCl), 100 mM glycine, and 0.4% (wt/vol) SDS. Ammonium persulfate and TEMED [final concentrations: 0.08% (wt/vol) and 0.08% (vt/vol), respectively] were added, after 30 min of degassing the gel solution. The gels were run at 8°C in a Hoefer SE600 unit (Hoefer, Holliston, MA) for 16 h at 230 constant volts. The electrode buffers were as described in Reiser and Kline (40) . The gels were silver-stained (5) to ensure detection of even minor amounts of either MHC isoform in all of the samples. The amounts (in arbitrary scan units) of MHC-␣ and MHC-␤ in each sample were measured by scanning densitometry, using a Hoefer GS300 densitometer. The results are expressed as the relative amount of MHC-␤ (i.e., percentage of total MHC) in each sample. Two-way ANOVA, with sex and condition (i.e., nonfailing and failing) being factors, was performed with SYSTAT 13, followed by Student's t-test for post hoc analysis. The significance level was set at 0.05. Fig. 1 . There was sufficient separation of the two MHC isoforms in all of the samples for reliable quantitation of their relative amounts by scanning densitometry. The mean relative amounts of MHC-␤ in the right and left atrium of all of the failing and nonfailing subjects are shown in Fig. 2 . Characteristics of the subjects, as well as the relative amounts of MHC-␤ in left and right atrial samples from each subject, are listed in Tables 1, 2, 3, and 4 . Two-way ANOVA was conducted separately for the left atrium and right atrium. The results are shown in Table 5 . The analysis indicated a significant condition (failing vs. nonfailing) effect in both atria (P ϭ 0.000 for both atria); that is, there was a greater relative amount of MHC-␤ among the samples from individuals in failure, independent of sex. There was a significant sex effect in the left (P ϭ 0.019), but not the right (P ϭ 0.742), atrium; that is, the left atrium of women had a greater amount of MHC-␤, independent of condition. There was a significant interaction between sex and condition in the right (P ϭ 0.012), but not the left (P ϭ 0.184), atrium; that is, the difference in the relative amount of MHC-␤ between nonfailing and failing right, but not the left, atria differed between men and women.
RESULTS
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Nonfailing subjects. P values for all of the post hoc t-tests are listed in Table 5 . Among the nonfailing subjects, the right atrium had more MHC-␤ than the left atrium in men, but not in women. The relative amount of MHC-␤ in the left atrium was twice as high in nonfailing women, compared with men, and the difference in the right atrium between nonfailing men and women was just above the level of significance.
Failing subjects. There was a significant increase in the relative amount of MHC-␤ in the failing left and right atria in men, as well as the left atrium of failing women. However, the right atrium did not differ between nonfailing and failing women. The left and right atrium differed in failing men, but not in failing women. The relative amount of MHC-␤ in the left atrium of nonfailing women was not different from the amount in the left atrium of failing men. Consistent with the lack of an interaction between sex and condition in the two-way ANOVA, neither the left or right atrium differed between failing men and women.
Age regressions. Linear regressions were run between the relative amount of MHC-␤ in the left and right atria of nonfailing and failing men and women and age (Fig. 3 ). There were no significant correlations for either atria in nonfailing or failing men. Significant positive correlations, with increasing age, were found in the nonfailing left and right atrium and in the failing right, but not left, atrium of women, with increases in the relative amount of MHC-␤ from 1.1% to 1.3% per year.
Results from an additional individual. Samples were obtained from a 26-year-old nonfailing woman who died suddenly (vehicular accident). The relative level of MHC-␤ in her left atrium (93%) was unusually high. This was the highest value among all of the left atrial samples (men and women). The relative amount of MHC-␤ in the right atrium of this subject was 36%, which was close to the mean value for nonfailing women. Her medical history suggested an abnormal sex hormone status (relative's statement in her medical record: "female organs ruptured"). The results from this individual were not included in any of the statistical comparisons in this study, due to the unusual existing condition.
DISCUSSION
The results of this study indicate that significant differences exist between men and women with respect to the relative amount of MHC-␤ in the atria of not only individuals identified as being in heart failure but also in individuals who are not in failure. Whereas there was not a significant interaction between sex and heart condition in the left atrium, there was a signifi- MHC, myosin heavy chain; MVA, motor vehicle accident; GSW, gunshot wound; CVA, cerebrovascular accident; W, white; B, black; LA, left atrium; RA, right atrium; LVEF, left ventricular ejection fraction; AF, atrial fibrillation; BW, body weight; HW, heart weight; DOP, dopamine; LIDO, lidocaine; THY, thyroxine; NE, norepinephrine; LAB, labetolol; DOB, dobutamine; EPI, epinephrine; LIS, lisinopril; EN, enalapril; ER, emergency room; MET, metoprolol; NIFED, nifediprine; POSS HTN MED, possible hypertension medication; TERAZ, terazosin; DOX, doxazosin; DILT, diltiazem; DIG, digoxin. A "hyperdynamic" heart was noted in the history of the subject with 85-90% LVEF.
cant interaction in the right atrium. Specifically, both atria differed in failing, compared with nonfailing, men, but there was a difference associated with failure in only the left atrium in women; the right atrium was the same in failing and nonfailing women. Furthermore, the left and right atria differed from each other in nonfailing men and in failing men, but not in nonfailing or failing women. Although failing men and women are similar, with respect to both atria, it is the change, or lack of change, which is associated with failure, in the right atrium, that differs between men and women. Therefore, although there are changes in the expression of MHC-␤ in the right and left atria of men and in the left atrium of women that are associated with failure, the right atrium in nonfailing women has a level of MHC-␤ that is not different from those in failure.
The finding of a significantly greater amount of MHC-␤ in the nonfailing female, compared with the nonfailing male, left atrium was not anticipated. Furthermore, the small but significant increases in MHC-␤ in the left and right atrium of healthy women, with increasing age, was not expected. Both of these findings suggest that sex differences exist in myosin isoform expression among healthy individuals. Kuro-o et al. (27) reported a greater amount of MHC-␤ in the left, compared with right, atrium in humans, based upon observations from immunohistochemical staining of samples from a relatively small number of individuals (five). We also detected a significantly greater level of MHC-␤ in the left, compared with right, atria of nonfailing men, but not women. Our results are, therefore, consistent with previous reports but, due to a larger sample size, our data has revealed sex-related differences in atrial MHC isoform expression, among nonfailing and failing subjects.
The impact of an increased amount of MHC-␤ in the left atrium is likely decreased rates of myocyte shortening and force generation and decreased power output, as well as increased economy of contraction (4, 17, 18, 25) . As demonstrated by Hinken and McDonald (19) , the increased level of MHC-␤ could provide protection against the deleterious consequences associated with ischemia. Therefore, the twofold greater amount of MHC-␤ in the left atrium of women, along with the small but significant increase in that level with increasing age, could impart an advantage to women following ischemic events. On the other hand, the greater amount of MHC-␤ could limit the role of the left atrium to augment diastolic filling of the left ventricle during instances of physiologic stress (26, 46) , due to the reduced power output associated with MHC-␤ compared with MHC-␣, when an increase in cardiac output is required. It has long been recognized that women normally have higher resting heart rates than men and that there are other significant sex-related differences in cardiac electrophysiology, such as frequency of tachycardia and other arrhythmias (reviewed in Refs. 12 and 55). Given that a higher heart rate could represent a greater workload on the heart, a greater relative amount of MHC-␤ in the left atrium of women could be viewed as an adaptation toward contractions with greater economy. An analogous adaptation occurs in functionally overloaded limb skeletal muscle in which there is an upregulation of slow-type MHC (the same protein as MHC-␤ in the heart) following surgical ablation of synergistic muscles (23) . Normal variations in resting heart rate in women are associated with different phases of the menstrual cycle (reviewed in Ref.
12). For example, Rosano et al. (42) reported that there is a higher frequency of ectopic beats in the ventricle occurring during the luteal phase of the cycle, and this variation was positively correlated with the level of plasma progesterone and inversely with plasma estradiol-17␤. It is possible that normally occurring episodes of tachycardia that are associated with the menstrual cycle could cumulatively promote the stable expression of a greater amount of MHC-␤ and thereby account for the observed sex-related difference in the left atrium in the present study. The loss of estrogen with menopause could also account for the greater level of MHC-␤ in the female left atrium since ovariectomy in animals models, with or without estrogen replacement, clearly demonstrates a dependence of cardiac myosin isoform expression on hormone levels (30, 37, 54) . The unusually high level of MHC-␤ in the left atrium of the 26-year-old nonfailing woman, with a possible abnormal sex hormone status (see RESULTS) , is consistent with a dependency of cardiac MHC isoform expression on circulating estrogen.
Seeburger et al. (44) reported that among patients undergoing mitral valve surgery, women were three times more likely to have valve stenosis and valve replacement was required more often among females in the same cohort of patients. Buttrick et al. (6) reported that there is an increase in the relative amount of the native myosin, V3, which has the MHC-␤ isoform, in the left atrium in association with mitral stenosis. It is possible, therefore, that the higher level of MHC-␤ in women than in men is associated with the greater occurrence of mitral valve stenosis in women, although there is insufficient information to evaluate the extent of stenosis among subjects in the present study and its contribution to the observations. An increase in left atrial workload, due to steno- (43) . Results from the same study indicated that that there is a much higher incidence atrial fibrillation (AF) among those with valve calcification. Therefore, it is possible that the increased level of MHC-␤ in the female left atrium is secondarily due to fibrillation that is associated with mitral valve calcification. There are several reports of an upregulation of the atrial expression of MHC-␤ in patients with AF (4, 8, 33) . However, others have reported that the cardiac MHC isoform expression is not affected by AF (21) . The cause of the twofold-greater level of MHC-␤ in the left atrium of healthy women is not known, but the results from several previous studies identify possible candidate mechanisms. AF was reported in only three nonfailing subjects and in only one failing female subject. Therefore, an association between AF and relative amount of MHC-␤ could not be assessed in these groups. AF was much more common in the failing men in this study. However, the relative amount of MHC-␤ in the left or right atria was not significantly different among failing men with or without AF. A variable in this study is the dissimilar medication history among the subjects. As discussed above, a change in heart rate has the potential to change MHC isoform expression (4, 8, 33) , and some medications have a tendency to alter heart rate. For example, Smith et al. (45) reported that milrinone use is associated with tachyarrhythmias after congenital heart surgery, and carvedilol has been reported to alter heart rate in patients with AF (24). Therefore, it is possible that medication use among the subjects in this study contributed to differences in MHC expression between groups of subjects (male vs. female and nonfailing vs. failing) and to variations within groups. However, inspection of the medication history and the relative amounts of MHC-␤ in the left and right atria in the tables does not identify any specific drug that might have skewed the obtained results.
